News Wire

Little is known about potential health risks
Product offers first combination of SGLT2 inhibitor and metformin
Combination product consists of Tresiba and Victoza
Entresto and Corlanor added to list of treatments
National Eye Institute report identifies trends by race, ethnicity, and gender
Decellularized vascular grafts will be studied in dialysis patients with ESRD
Generic companies aren’t required to update safety labeling
Company revises tens of thousands of analyses
SGLT2 inhibitor is available as Invokana and Invokamet
New sensor technology could be in clinics next year
Diazepam spray doesn’t measure up to rectal gel
Product is first myeloma-targeted monoclonal antibody approved in U.S.
Results expected in 2020
Doctors’ errors kill hundreds of thousands of people in U.S. each year

Pages